|Date||Date of Registration : Mar 01, 2017
Date of Revision : Mar 01, 2017
|Country / Area||Slovak|
8802 Bio-medicine and therapeutics (vaccines, biological products, bio-diagnostics / pharmaceuticals, gene-diagnostics / therapeutics )
8803 Bio-electronics and bio-mechanics (medical devices, diagnostic equipment, care products,labowares / equipment)
|Target Country / Area||All Countries / Areas|
*Attention: JETRO shall not take any responsibility for the contents provided by users. Please take note of the fact that JETRO leaves the exactness and reliability of the contents to users' judgment.
Provide Technology of Antibodies for Diagnostic and Research
<< DESCRIPTION >>
We will offer technology to produce andibodies which could be interesting for pharmaceutical company developing a new drug/diagnostic test, researcher working on his project or pathologist needing the antibody for diagnosis.
Our rabbit clonal antibodies are developed using a novel in-vitro cloning technology which enables the preparation of a pure immunoglobulin fraction corresponding to a single clone of B lymphocytes. The obtained immunoglobulin recognizes one single linear epitope on the antigen molecule, making this antibody comparable in quality to its monoclonal analogue.
Moreover, the influence of the protein tertiary structure-requently present in epitopes recognized by monoclonal antibodies-is eliminated in immunoglobulins corresponding to the clonal antibody.
*Relation with the technology: owner
*Examples of the field of application
This technology can be used for new antibodies development wherever the antibodies are used, e.g. pathology diagnostic applications, pharmaceutical industry, academia
-Pharmaceutical companies in need of antibodies, diagnostic company, academia
-The partner should have a knowledge about antibodies, their use, their handling; involved people have usually university degree, research background, and worked with antibodies in research areas and/or diagnostic applications.
SlovakFeb 27, 2017 RegistrationFeb 27, 2017 Revision
Total Sum of CONTACT Received : 0